Crossref journal-article
Elsevier BV
Neuroscience Letters (78)
Bibliography

Shi, M., Zabetian, C. P., Hancock, A. M., Ginghina, C., Hong, Z., Yearout, D., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J., Leverenz, J. B., & Zhang, J. (2010). Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson’s disease. Neuroscience Letters, 480(1), 78–82.

Authors 13
  1. Min Shi (first)
  2. Cyrus P. Zabetian (additional)
  3. Aneeka M. Hancock (additional)
  4. Carmen Ginghina (additional)
  5. Zhen Hong (additional)
  6. Dora Yearout (additional)
  7. Kathryn A. Chung (additional)
  8. Joseph F. Quinn (additional)
  9. Elaine R. Peskind (additional)
  10. Douglas Galasko (additional)
  11. Joseph Jankovic (additional)
  12. James B. Leverenz (additional)
  13. Jing Zhang (additional)
References 20 Referenced 185
  1. 10.1159/000112832 / Neurodegener. Dis. / Red blood cells are the major source of alpha-synuclein in blood by Barbour (2008)
  2. 10.1002/mds.22928 / Mov. Disord. / Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment by Duran (2010)
  3. 10.1096/fj.03-1449com / FASEB J. / Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease by El-Agnaf (2006)
  4. 10.1080/00365510601161497 / Scand. J. Clin. Lab. Invest. / Determination of alpha-synuclein concentration in human plasma using ELISA by Fjorback (2007)
  5. 10.1093/brain/awq008 / Brain / DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease by Hong (2010)
  6. 10.1002/mds.10557 / Mov. Disord. / Neuropathological spectrum of synucleinopathies by Jellinger (2003)
  7. 10.1007/s00702-005-0427-9 / J. Neural Transm. / The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy by Lee (2006)
  8. 10.3233/JAD-2002-4406 / J. Alzheimers Dis. / Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects by Li (2002)
  9. 10.1016/j.expneurol.2006.12.006 / Exp. Neurol. / Plasma alpha-synuclein is decreased in subjects with Parkinson's disease by Li (2007)
  10. 10.1097/nen.0b013e3180415e42 / J. Neuropathol. Exp. Neurol. / The etiopathogenesis of Parkinson disease and suggestions for future research. Part I by Litvan (2007)
  11. 10.1016/j.neulet.2007.11.027 / Neurosci. Lett. / Secretion of DJ-1 into the serum of patients with Parkinson's disease by Maita (2008)
  12. 10.1016/j.neulet.2005.02.030 / Neurosci. Lett. / Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease by Michell (2005)
  13. 10.1016/j.expneurol.2008.06.004 / Exp. Neurol. / Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration by Mollenhauer (2008)
  14. 10.1016/j.neulet.2008.11.015 / Neurosci. Lett. / Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss? by Ohrfelt (2009)
  15. 10.1016/j.neulet.2009.08.074 / Neurosci. Lett. / Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients by Saito (2009)
  16. 10.1093/hmg/ddm159 / Hum. Mol. Genet. / Parkinson's disease by Thomas (2007)
  17. 10.1016/j.bbrc.2006.08.024 / Biochem. Biophys. Res. Commun. / Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease by Tokuda (2006)
  18. 10.1016/j.febslet.2008.06.043 / FEBS Lett. / DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains by Tsuboi (2008)
  19. 10.1016/j.neulet.2007.08.010 / Neurosci. Lett. / Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease by Waragai (2007)
  20. 10.1016/j.bbrc.2006.05.011 / Biochem. Biophys. Res. Commun. / Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease by Waragai (2006)
Dates
Type When
Created 15 years, 2 months ago (June 11, 2010, 2:42 a.m.)
Deposited 5 years, 5 months ago (March 11, 2020, 2:02 p.m.)
Indexed 5 hours, 39 minutes ago (Sept. 4, 2025, 10:10 a.m.)
Issued 15 years, 1 month ago (Aug. 1, 2010)
Published 15 years, 1 month ago (Aug. 1, 2010)
Published Print 15 years, 1 month ago (Aug. 1, 2010)
Funders 2
  1. National Institutes of Health 10.13039/100000002

    Region: Americas

    gov (National government)

    Labels3
    1. Institutos Nacionales de la Salud
    2. US National Institutes of Health
    3. NIH
    Awards1
    1. ES004696, NS057567, AG025327, AG033398, NS060252, NS062684, AG005136 and AG008017
  2. Michael J. Fox Foundation 10.13039/100000864 Michael J. Fox Foundation for Parkinson's Research

    Region: Americas

    gov (Trusts, charities, foundations (both public and private))

    Labels7
    1. Michael J. Fox Foundation
    2. Fundación Michael J. Fox
    3. The Michael J. Fox Foundation for Parkinson's Research
    4. The Michael J. Fox Foundation
    5. Michael J Fox Foundation for Parkinson's Disease Research
    6. Michael J Fox Foundation for Parkinson's Research
    7. MJFF

@article{Shi_2010, title={Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson’s disease}, volume={480}, ISSN={0304-3940}, url={http://dx.doi.org/10.1016/j.neulet.2010.06.009}, DOI={10.1016/j.neulet.2010.06.009}, number={1}, journal={Neuroscience Letters}, publisher={Elsevier BV}, author={Shi, Min and Zabetian, Cyrus P. and Hancock, Aneeka M. and Ginghina, Carmen and Hong, Zhen and Yearout, Dora and Chung, Kathryn A. and Quinn, Joseph F. and Peskind, Elaine R. and Galasko, Douglas and Jankovic, Joseph and Leverenz, James B. and Zhang, Jing}, year={2010}, month=aug, pages={78–82} }